chr1-154925085-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_006556.4(PMVK):c.*44T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0067 ( 0 hom., cov: 16)
Exomes 𝑓: 0.056 ( 3 hom. )
Failed GnomAD Quality Control
Consequence
PMVK
NM_006556.4 3_prime_UTR
NM_006556.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.18
Genes affected
PMVK (HGNC:9141): (phosphomevalonate kinase) This gene encodes a peroxisomal enzyme that is a member of the galactokinase, homoserine kinase, mevalonate kinase, and phosphomevalonate kinase (GHMP) family of ATP-dependent enzymes. The encoded protein catalyzes the conversion of mevalonate 5-phosphate to mevalonate 5-diphosphate, which is the fifth step in the mevalonate pathway of isoprenoid biosynthesis. Mutations in this gene are linked to certain types of porokeratosis including disseminated superficial porokeratosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 1-154925085-A-C is Benign according to our data. Variant chr1-154925085-A-C is described in ClinVar as [Benign]. Clinvar id is 1254973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PMVK | NM_006556.4 | c.*44T>G | 3_prime_UTR_variant | 5/5 | ENST00000368467.4 | ||
PMVK | NM_001323011.3 | c.*44T>G | 3_prime_UTR_variant | 5/5 | |||
PMVK | NM_001323012.3 | c.*44T>G | 3_prime_UTR_variant | 5/5 | |||
PMVK | NM_001348696.2 | c.*44T>G | 3_prime_UTR_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PMVK | ENST00000368467.4 | c.*44T>G | 3_prime_UTR_variant | 5/5 | 1 | NM_006556.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 414AN: 62072Hom.: 0 Cov.: 16 FAILED QC
GnomAD3 genomes
AF:
AC:
414
AN:
62072
Hom.:
Cov.:
16
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0632 AC: 12030AN: 190480Hom.: 0 AF XY: 0.0568 AC XY: 5947AN XY: 104710
GnomAD3 exomes
AF:
AC:
12030
AN:
190480
Hom.:
AF XY:
AC XY:
5947
AN XY:
104710
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0561 AC: 32805AN: 584676Hom.: 3 Cov.: 15 AF XY: 0.0562 AC XY: 16554AN XY: 294534
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
32805
AN:
584676
Hom.:
Cov.:
15
AF XY:
AC XY:
16554
AN XY:
294534
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00666 AC: 414AN: 62132Hom.: 0 Cov.: 16 AF XY: 0.00639 AC XY: 190AN XY: 29714
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
414
AN:
62132
Hom.:
Cov.:
16
AF XY:
AC XY:
190
AN XY:
29714
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at